?????DNA?????? 2025-2034

????????DNA???????2024??21?8000????????2034?????113?3000?????????????????2025???2034????????????CAGR?17.91?????????????

?????DNA??????????

2024?????????????DNA??????????
???????????????????????????????????
????????GMP???????????????????????????????????????????????
???????????????????2024???????DNA??????????
??????????????????????????????????????????????
???????????????????????????????????????????
??????DNA????????????????????????????????????
?????????????????????????DNA??????????????????
?????????????????????????????????????????

??????????

????	??
2025??????	26?4000????
2034????????	113?3000????
2025???2034?????????	???????CAGR?17.91?

?????DNA??????????????????????????????????????????????????????????DNA?????DNA????????????????DNA??????????????????????????DNA????????????????????????????ATMP??????????????????????

2024?3??Novel Bio??????DNA?????????????????????Culture Biosciences?????????????Novel Bio?Culture Biosciences????????????????????NBx?????????????????DNA?????????????????????????????

?????DNA??????????

2023?6??INADcure??????????????????????????????????????????????????????????????????????????I/II??????????pDNA?????????

????????

?????CEO ??????

ProBio ? CEO?Allen Guo ???????????? DNA ?????????????????????????????????????????????????????????????????????????????????????????????????

????????????????????

????????????? 21 ????????????????????????????????????????????????????????????????????????????????????????????????????BioNTech ?????????????????????????????????????????????????

AI ?????? DNA ??????????????

AI ?????????????????????????????????????????????????????ML?? AI ??????????????
???????????????ML ??? AI ????????????????????????????????
AI ??????????????????????????????????????????????????????????????????????????????? AI ???????????????????????????????????
AI?????????????????????????????????????????????????????????????????????AI????????????????????

?????

2024?4???????????????????Axovia Therapeutics????????????????????????????????????BBS???????????Axovia?????????????????????????????????????

?????

?????DNA??????????????????????????????????????????????????????????????????????????????????????????????

2024???????????????NIH?????????????????DNA???????rDNA?????????????????????????????????????????????????????????????????????????????????????????

???????????????DNA?????????????????????????????????????????????????????????????????????

??????????????APAC?

?????????APAC?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????

????

???????????????????
????1947?
????????????????????????

??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????

???????????
????1949?
??????????????????D.C.

??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??????????????????????????????????????????????????????????????

????????
????1984?
??????????????????D.C.

?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????

?????????????????????? vs ??? vs ????????????? 2021-24???????????

?	?????????????????	???????	?????????????
2024	40,49,989	76,23,02,000	2,387,500
2023	41,29,409	75,58,21,000	2,38,90,000
2022	39,76,060	69,15,30,000	2,66,43,000
2021	35,40,160	57,74,26,000	2,48,02,000

�

?????DNA???????

???????????????
VGXI, Inc.
???????????
????????????????????????????
??????
????????????
??????????????
??????????????
?????????????????????
?????????????
?????????

発行元 Ajit Bansod

参考文献

Primary Research Interviews

Industry experts from plasmid DNA production companies (e.g., VGXI, Aldevron, Charles River)
R&D heads from biotechnology and gene therapy companies
Regulatory consultants specializing in DNA therapeutics
Procurement managers from pharmaceutical companies

Stakeholders

Plasmid DNA manufacturing companies (CDMOs, CMOs)
Biotech firms engaged in gene therapy, vaccines, and cell therapy
Academic and government research institutions
Regulatory authorities (e.g., FDA, EMA)
Investors and venture capitalists in biotech manufacturing

Databases

Statista
Bloomberg Terminal
EMIS Database
Precedence Research proprietary databases (if applicable)

Magazines

Genetic Engineering & Biotechnology News (GEN)
BioPharma Dive
Fierce Biotech
Pharmaceutical Technology
Contract Pharma Magazine

Journals

Nature Biotechnology
Journal of Gene Medicine
Human Gene Therapy
Biotechnology Advances
Molecular Therapy

Newspapers

The Wall Street Journal (Health & Pharma section)
The New York Times (Science section)
Financial Times (Biotech Industry)
The Economic Times (Healthcare/Pharma)

Associations

Biotechnology Innovation Organization (BIO)
Alliance for Regenerative Medicine (ARM)
European Biopharmaceutical Enterprises (EBE)
American Society of Gene & Cell Therapy (ASGCT)

Public Domain Sources

U.S. FDA website (regulatory guidance on plasmid-based products)
ClinicalTrials.gov (ongoing trials using plasmid DNA)
WHO reports on vaccine manufacturing
PubMed and NIH reports
EMA public documents

Proprietary Elements

Precedence Research's proprietary market modeling tools
Company financials and strategic roadmaps from investor reports
Expert panel validation and in-house analyst insights
Survey data from industry professionals and key opinion leaders (KOLs)

Plasmid DNA Manufacturing Market - Databook 2025 to 2034 収益, By Product 2024年から2034年（百万米ドル）

サブセグメント	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Viral Vectors	-	-	-	-	-	-	-	-	-	-	-
Plasmid DNA	-	-	-	-	-	-	-	-	-	-	-
Non-Viral	-	-	-	-	-	-	-	-	-	-	-
Electroporation	-	-	-	-	-	-	-	-	-	-	-
Lipid/Polymer	-	-	-	-	-	-	-	-	-	-	-
Nanoparticles	-	-	-	-	-	-	-	-	-	-	-
Others	-	-	-	-	-	-	-	-	-	-	-

Plasmid DNA Manufacturing Market - Databook 2025 to 2034 収益, By Application 2024年から2034年（百万米ドル）

サブセグメント	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Gene Therapy	-	-	-	-	-	-	-	-	-	-	-
DNA Vaccines	-	-	-	-	-	-	-	-	-	-	-
Immunotherapy	-	-	-	-	-	-	-	-	-	-	-
Others	-	-	-	-	-	-	-	-	-	-	-

Plasmid DNA Manufacturing Market - Databook 2025 to 2034 収益, By Disease 2024年から2034年（百万米ドル）

サブセグメント	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Infectious Disease	-	-	-	-	-	-	-	-	-	-	-
Genetic Disorder	-	-	-	-	-	-	-	-	-	-	-
Cancer	-	-	-	-	-	-	-	-	-	-	-

PDFをダウンロード

?????DNA?????? 2025-2034

?????DNA??????????

??????????

?????DNA??????????

????????

AI ?????? DNA ??????????????

?????

?????

????

?????DNA???????

参考文献

Primary Research Interviews

Stakeholders

Databases

Magazines

Journals

Newspapers

Associations

Public Domain Sources

Proprietary Elements

Plasmid DNA Manufacturing Market - Databook 2025 to 2034 収益, By Product 2024年から2034年（百万米ドル）

Plasmid DNA Manufacturing Market - Databook 2025 to 2034 収益, By Application 2024年から2034年（百万米ドル）

Plasmid DNA Manufacturing Market - Databook 2025 to 2034 収益, By Disease 2024年から2034年（百万米ドル）

購入手続きへ進む

カスタマイズされたソリューションをお探しですか？

カスタマイズの50％は当社が負担します。インサイト、トレンド、戦略計画をあなたのニーズに合わせて最適化します。

データブックをダウンロード

パートナー企業